论文部分内容阅读
本月全球药品研发进展取得成效的药物有48个,较上月减少了4个,除进入Ⅲ期阶段的药物数量较上月略有增加外,进入注册和注册前阶段的药品数量均略有下降。进入注册阶段的有26个,比上月减少1个。其中7个为全球首次注册的新活性物质、新制剂和新适应证,其余19个均为在新市场补充注册。本月全球首次注册7个药品,较上月增加1个。其中4个为新活性物质,3个为新制剂。4个新活性物质分
There were 48 drugs that made progress in global drug development this month, down 4 from the previous month. The number of drugs entering the pre-registration and pre-registration phase was slightly lower except for the slight increase in the number of drugs entering the phase III phase from the previous month. decline. Into the registration stage of 26, a decrease over the previous month. Seven of these were the first new active substances, new preparations and new indications registered in the world, and the remaining 19 were newly registered in the new markets. This month the world’s first registration of seven drugs, an increase of the previous month. Four of them were new active substances and three were new preparations. 4 new active substances points